Allen Moseley joined NMP in 1998 and leads the firm’s healthcare practice focused primarily in healthcare information technology, healthcare services and medical devices. He currently represents NMP on the boards of Diabetes Care Group, Navitas Lease Finance, RemitDATA, Valor Healthcare and Wellcentive. Allen also oversees the firm’s investments in Direct Insurance and Lanx. Allen was previously a director for several prior NMP investments including Apex Analytix (acquired by PNC Equity), Bloodhound Technologies (acquired by Verisk Analytics), Renal CarePartners (acquired by Ambulatory Services of America), Senior Whole Health (acquired by TA Associates), U.S. Radiosurgery (acquired by Alliance Imaging) and Witness Systems (board observer, IPO and acquired by Verint Systems).
Prior to joining NMP, Allen was in the corporate finance group at The Robinson-Humphrey Company, an investment banking firm previously owned by Citigroup and most recently acquired by SunTrust. Allen worked extensively in the healthcare and business services industries, advising on a number of initial public offerings, M&A transactions and private placements. He was also involved in R-H Capital Partners, the private equity investment arm of the firm. Previously, Allen held investment banking positions with Bowles Hollowell Conner & Company and Merrill Lynch & Co.
Allen currently serves on the Board of Trustees of the Georgia Research Alliance and the Technology Association of Georgia. He was recently Chairman of Venture Atlanta and Chairman of the Technology Association of Georgia. Allen received a BA from the University of North Carolina at Chapel Hill, where he was a member of Phi Beta Kappa, and an MBA from Harvard Business School.